Sandbox vidit3: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
! Dosage | ! Dosage | ||
|- | |||
---- | |||
! Direct FXa inhibitors | |||
|- | |- | ||
Line 27: | Line 32: | ||
|- | |- | ||
| Bivalirudin | | [[Bivalirudin]] | ||
| Bolus: None <br> Continuous infusion: <br> | | Bolus: None <br> Continuous infusion: <br> | ||
Line 37: | Line 42: | ||
|- | |- | ||
---- | ---- | ||
| Danaparoid | |||
! Indirect FXa inhibitors | |||
|- | |||
| [[Danaparoid]] | |||
| Bolus: <br> | | Bolus: <br> |
Revision as of 16:04, 2 January 2014
Agent | Dosage |
---|---|
Direct FXa inhibitors | |
Argatroban | Bolus: None Continuous infusion:
|
Lepirudin | Bolus:0.2 mg/kg (only for life- or limb-threatening thrombosis) Continuous infusion:
|
Bivalirudin | Bolus: None Continuous infusion:
|
Indirect FXa inhibitors | |
Danaparoid | Bolus:
Accelerated initial infusion: 400 U/hour X 4 hours, then 300 U/hour X 4 hours
|